HEADER SERINE PROTEASE HOMOLOG 05-MAR-97 1AE5 TITLE HUMAN HEPARIN BINDING PROTEIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEPARIN BINDING PROTEIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CAP37, AZUROCIDIN; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 CELL_LINE: SF-900; SOURCE 6 EXPRESSION_SYSTEM: UNIDENTIFIED BACULOVIRUS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10469; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: ACMNPV; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: SF-900; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: VIRUS KEYWDS SERINE PROTEASE HOMOLOG, ENDOTOXIN BINDING, HEPARIN BINDING, KEYWDS 2 INFLAMMATION, ANTIBACTERIAL, CAP37, AZUROCIDIN, GLYCOSYLATED PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR L.F.IVERSEN,J.S.KASTRUP,S.E.BJORN,P.B.RASMUSSEN,F.C.WIBERG, AUTHOR 2 H.J.FLODGAARD,I.K.LARSEN REVDAT 6 25-DEC-24 1AE5 1 REMARK LINK REVDAT 5 02-AUG-23 1AE5 1 HETSYN REVDAT 4 29-JUL-20 1AE5 1 COMPND REMARK HETNAM LINK REVDAT 4 2 1 SITE REVDAT 3 13-JUL-11 1AE5 1 VERSN REVDAT 2 24-FEB-09 1AE5 1 VERSN REVDAT 1 11-MAR-98 1AE5 0 JRNL AUTH L.F.IVERSEN,J.S.KASTRUP,S.E.BJORN,P.B.RASMUSSEN,F.C.WIBERG, JRNL AUTH 2 H.J.FLODGAARD,I.K.LARSEN JRNL TITL STRUCTURE OF HBP, A MULTIFUNCTIONAL PROTEIN WITH A SERINE JRNL TITL 2 PROTEINASE FOLD. JRNL REF NAT.STRUCT.BIOL. V. 4 265 1997 JRNL REFN ISSN 1072-8368 JRNL PMID 9095193 JRNL DOI 10.1038/NSB0497-265 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH L.F.IVERSEN,J.S.KASTRUP,I.K.LARSEN,S.E.BJORN,P.B.RASMUSSEN, REMARK 1 AUTH 2 F.C.WIBERG,H.J.FLODGAARD REMARK 1 TITL CRYSTALLIZATION AND MOLECULAR REPLACEMENT SOLUTION OF HUMAN REMARK 1 TITL 2 HEPARIN BINDING PROTEIN REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 52 1222 1996 REMARK 1 REFN ISSN 0907-4449 REMARK 1 REFERENCE 2 REMARK 1 AUTH P.B.RASMUSSEN,S.BJORN,S.HASTRUP,P.F.NIELSEN,K.NORRIS,L.THIM, REMARK 1 AUTH 2 F.C.WIBERG,H.FLODGAARD REMARK 1 TITL CHARACTERIZATION OF RECOMBINANT HUMAN HBP/CAP37/AZUROCIDIN, REMARK 1 TITL 2 A PLEIOTROPIC MEDIATOR OF INFLAMMATION-ENHANCING LPS-INDUCED REMARK 1 TITL 3 CYTOKINE RELEASE FROM MONOCYTES REMARK 1 REF FEBS LETT. V. 390 109 1996 REMARK 1 REFN ISSN 0014-5793 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : TNT REMARK 3 AUTHORS : TRONRUD,TEN EYCK,MATTHEWS REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 12176 REMARK 3 REMARK 3 USING DATA ABOVE SIGMA CUTOFF. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : NULL REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 USING ALL DATA, NO SIGMA CUTOFF. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.1920 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.266 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.00 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 12176 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1687 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 28 REMARK 3 SOLVENT ATOMS : 63 REMARK 3 REMARK 3 WILSON B VALUE (FROM FCALC, A**2) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. RMS WEIGHT COUNT REMARK 3 BOND LENGTHS (A) : 0.016 ; NULL ; NULL REMARK 3 BOND ANGLES (DEGREES) : 2.400 ; NULL ; NULL REMARK 3 TORSION ANGLES (DEGREES) : 18.430; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES (A) : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES (A) : NULL ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS (A**2) : 2.600 ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS (A) : NULL ; NULL ; NULL REMARK 3 REMARK 3 INCORRECT CHIRAL-CENTERS (COUNT) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 RESTRAINT LIBRARIES. REMARK 3 STEREOCHEMISTRY : NULL REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 THERE IS A DISORDERED REGION IN THE STRUCTURE INVOLVING REMARK 3 RESIDUES 44 - 48. REMARK 4 REMARK 4 1AE5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000170705. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : SEP-96 REMARK 200 TEMPERATURE (KELVIN) : 300 REMARK 200 PH : 7.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : EMBL/DESY, HAMBURG REMARK 200 BEAMLINE : X11 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.999 REMARK 200 MONOCHROMATOR : MIRRORS REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12176 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 4.700 REMARK 200 R MERGE (I) : 0.08900 REMARK 200 R SYM (I) : 0.08900 REMARK 200 FOR THE DATA SET : 14.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.34 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.6 REMARK 200 DATA REDUNDANCY IN SHELL : 3.90 REMARK 200 R MERGE FOR SHELL (I) : 0.26400 REMARK 200 R SYM FOR SHELL (I) : 0.26400 REMARK 200 FOR SHELL : 4.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1PPF REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 7.2 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 19.59500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 50.68000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.06000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 50.68000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 19.59500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.06000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN A 46 REMARK 465 ASN A 47 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 ND2 ASN A 145 O5 NAG A 411 1.94 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 98 CD GLU A 98 OE2 0.070 REMARK 500 GLU A 151 CD GLU A 151 OE2 0.078 REMARK 500 GLU A 182 CD GLU A 182 OE1 0.075 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 59 CB - CG - OD1 ANGL. DEV. = 8.2 DEGREES REMARK 500 ASP A 59 CB - CG - OD2 ANGL. DEV. = -8.8 DEGREES REMARK 500 ASP A 89 CB - CG - OD1 ANGL. DEV. = 5.5 DEGREES REMARK 500 ASP A 89 CB - CG - OD2 ANGL. DEV. = -7.1 DEGREES REMARK 500 ASP A 96 CB - CG - OD1 ANGL. DEV. = -5.4 DEGREES REMARK 500 ASP A 96 CB - CG - OD2 ANGL. DEV. = 5.8 DEGREES REMARK 500 ARG A 132 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 ARG A 142 NE - CZ - NH2 ANGL. DEV. = -4.3 DEGREES REMARK 500 ASP A 152 CB - CG - OD2 ANGL. DEV. = -5.4 DEGREES REMARK 500 ARG A 166 NE - CZ - NH1 ANGL. DEV. = 4.4 DEGREES REMARK 500 ARG A 205 NE - CZ - NH1 ANGL. DEV. = 3.1 DEGREES REMARK 500 ARG A 210 NE - CZ - NH1 ANGL. DEV. = 4.3 DEGREES REMARK 500 ARG A 210 NE - CZ - NH2 ANGL. DEV. = -3.6 DEGREES REMARK 500 ASP A 211 CB - CG - OD1 ANGL. DEV. = 5.9 DEGREES REMARK 500 PRO A 222 C - N - CD ANGL. DEV. = -31.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 10 19.32 59.02 REMARK 500 HIS A 32 143.97 -170.15 REMARK 500 PHE A 43 49.98 -106.25 REMARK 500 TYR A 58 -67.68 -135.95 REMARK 500 GLU A 64 56.89 30.98 REMARK 500 CYS A 154 -165.00 -113.42 REMARK 500 THR A 165 -156.78 -74.40 REMARK 500 ARG A 166 -85.24 -86.62 REMARK 500 SER A 190 -63.48 -107.09 REMARK 500 PRO A 195 126.28 -25.49 REMARK 500 PRO A 222 -45.30 -18.79 REMARK 500 REMARK 500 REMARK: NULL DBREF 1AE5 A 1 225 UNP P20160 CAP7_HUMAN 27 251 SEQRES 1 A 225 ILE VAL GLY GLY ARG LYS ALA ARG PRO ARG GLN PHE PRO SEQRES 2 A 225 PHE LEU ALA SER ILE GLN ASN GLN GLY ARG HIS PHE CYS SEQRES 3 A 225 GLY GLY ALA LEU ILE HIS ALA ARG PHE VAL MET THR ALA SEQRES 4 A 225 ALA SER CYS PHE GLN SER GLN ASN PRO GLY VAL SER THR SEQRES 5 A 225 VAL VAL LEU GLY ALA TYR ASP LEU ARG ARG ARG GLU ARG SEQRES 6 A 225 GLN SER ARG GLN THR PHE SER ILE SER SER MET SER GLU SEQRES 7 A 225 ASN GLY TYR ASP PRO GLN GLN ASN LEU ASN ASP LEU MET SEQRES 8 A 225 LEU LEU GLN LEU ASP ARG GLU ALA ASN LEU THR SER SER SEQRES 9 A 225 VAL THR ILE LEU PRO LEU PRO LEU GLN ASN ALA THR VAL SEQRES 10 A 225 GLU ALA GLY THR ARG CYS GLN VAL ALA GLY TRP GLY SER SEQRES 11 A 225 GLN ARG SER GLY GLY ARG LEU SER ARG PHE PRO ARG PHE SEQRES 12 A 225 VAL ASN VAL THR VAL THR PRO GLU ASP GLN CYS ARG PRO SEQRES 13 A 225 ASN ASN VAL CYS THR GLY VAL LEU THR ARG ARG GLY GLY SEQRES 14 A 225 ILE CYS ASN GLY ASP GLY GLY THR PRO LEU VAL CYS GLU SEQRES 15 A 225 GLY LEU ALA HIS GLY VAL ALA SER PHE SER LEU GLY PRO SEQRES 16 A 225 CYS GLY ARG GLY PRO ASP PHE PHE THR ARG VAL ALA LEU SEQRES 17 A 225 PHE ARG ASP TRP ILE ASP GLY VAL LEU ASN ASN PRO GLY SEQRES 18 A 225 PRO GLY PRO ALA MODRES 1AE5 ASN A 114 ASN GLYCOSYLATION SITE MODRES 1AE5 ASN A 145 ASN GLYCOSYLATION SITE HET NAG A 401 14 HET NAG A 411 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 2 NAG 2(C8 H15 N O6) FORMUL 4 HOH *63(H2 O) HELIX 1 1 ALA A 40 PHE A 43 5 4 HELIX 2 2 GLU A 151 GLN A 153 5 3 HELIX 3 3 VAL A 206 ASN A 218 5 13 SHEET 1 A 7 GLN A 69 PHE A 71 0 SHEET 2 A 7 THR A 52 LEU A 55 -1 N LEU A 55 O GLN A 69 SHEET 3 A 7 LEU A 15 ASN A 20 -1 N GLN A 19 O THR A 52 SHEET 4 A 7 ARG A 23 HIS A 32 -1 N GLY A 28 O ALA A 16 SHEET 5 A 7 PHE A 35 THR A 38 -1 N MET A 37 O ALA A 29 SHEET 6 A 7 MET A 91 LEU A 95 -1 N LEU A 93 O VAL A 36 SHEET 7 A 7 ILE A 73 GLU A 78 -1 N SER A 77 O LEU A 92 SHEET 1 B 6 ARG A 142 THR A 147 0 SHEET 2 B 6 ARG A 122 GLY A 127 -1 N GLY A 127 O ARG A 142 SHEET 3 B 6 PRO A 178 CYS A 181 -1 N VAL A 180 O GLN A 124 SHEET 4 B 6 LEU A 184 SER A 192 -1 N GLY A 187 O LEU A 179 SHEET 5 B 6 ASP A 201 ARG A 205 -1 N THR A 204 O VAL A 188 SHEET 6 B 6 ASN A 158 THR A 161 -1 N THR A 161 O ASP A 201 SSBOND 1 CYS A 26 CYS A 42 1555 1555 2.07 SSBOND 2 CYS A 123 CYS A 181 1555 1555 2.03 SSBOND 3 CYS A 154 CYS A 160 1555 1555 2.02 SSBOND 4 CYS A 171 CYS A 196 1555 1555 2.05 LINK ND2 ASN A 114 C1 NAG A 401 1555 1555 1.47 LINK ND2 ASN A 145 C1 NAG A 411 1555 1555 1.44 CISPEP 1 GLY A 199 PRO A 200 0 -0.17 CRYST1 39.190 66.120 101.360 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025517 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015124 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009866 0.00000